SCHEMBL7058731

SCHEMBL7058731

Cc1cc(=O)oc2cc(OP(=O)(Cl)Cl)ccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.66
KDM4E B2RXH2 11/20 0.66
HSD17B10 Q99714 7/20 0.66
HPGD P15428 6/20 0.66
GAA P10253 8/20 0.59
GLA P06280 7/20 0.59
CA2 P00918 1/20 0.58
STS P08842 1/20 0.58
KMT2A Q03164 4/20 0.56
MAPT P10636 2/20 0.56
TP53 P04637 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ALDH2 P05091 2/20 0.56
TSHR P16473 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NPC1 O15118 2/20 0.54
CASP3 P42574 2/20 0.54
RAB9A P51151 2/20 0.54
SENP8 Q96LD8 2/20 0.54
SENP7 Q9BQF6 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20703812 0.88 ALDH1A1 (0.69) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL140039 0.85 ALDH1A1 (0.66) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL4610846 0.85 ALDH1A1 (0.66) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL29391759 0.85 ALDH1A1 (0.66) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL380623 0.85 ALDH1A1 (0.66) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL1023154 0.84 ALDH1A1 (0.68) ALDH1A1KDM4EHSD17B10HPGDGAA
Silver SCHEMBL7614148 0.84 ALDH1A1 (0.64) ALDH1A1KDM4EHSD17B10HPGDGAA
Phosphoric Acid SCHEMBL9224251 0.84 ALDH1A1 (0.64) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL4610784 0.84 ALDH1A1 (0.64) ALDH1A1KDM4EHSD17B10HPGDGAA
Lithium Ion SCHEMBL1871467 0.84 ALDH1A1 (0.64) ALDH1A1KDM4EHSD17B10HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0949266-B1 Novel potentially fluorogenic compounds BIOSYNTH AG (CH) 2003-05-28 EP disclosed
US-6558917-B2 Fluorogenic compounds which become fluorogenic and, hence fluoroscopically detectable upon contact with certain microorganisms or substances produced by such microorganisms BIOSYNTH AG (CH) 2003-05-06 US disclosed
US-20030032080-A1 Novel potentially fluorogenic compounds and plating media containing same BIOSYNTH AG (CH) 2003-02-13 US disclosed
US-6416970-B1 COMPOUNDS INCLUDING 4-METHYLUMBELLIFERYL MYO-INOSITOL-1-PHOSPHATE AND SALTS WITH ORGANIC AND INORGANIC BASES BIOSYNTH AG (CH) 2002-07-09 US disclosed
EP-0949266-A1 Novel potentially fluorogenic compounds Biosynth AG (CH) 1999-10-13 EP disclosed
WO-1999048899-A1 NOVEL POTENTIALLY FLUOROGENIC COMPOUNDS BIOSYNTH AG (CH) 1999-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032080-A1 Novel potentially fluorogenic compounds and plating media containing same INPPL1, PLCG1, PIP4K2C ALDH1A1 659/4885KDM4E 1165/4885HSD17B10 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.